RxDoctor Payments Data

Sherry Yu, MD

MOHS-Micrographic Surgery · Macedonia, OHNPI 1427411149

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $451 and has fallen 51.2% since, to $220 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in OH, where the typical reported total is $1,196.

$823in general payments, 2019–2025

Across 34 payments — averaging $24.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$136
  • Regeneron Healthcare Solutions, Inc.$107
  • Regeneron$86
  • Organogenesis Inc.$74
  • LEO Pharma Inc.$67
  • Boehringer Ingelheim$53
  • plus $299 from 11 others

What the payments were for

  • Food & beverage$823100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$823 in reported general payments places this provider in the 30th percentile of 35 mohs-micrographic surgery providers in Ohio.

See all mohs-micrographic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$303,558
Medicare patients
280
Services billed
1,172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin92$503
Gentamicin Sulfate13$500
Triamcinolone Acetonide21$264
Doxycycline Hyclate23$170
Ciprofloxacin Hcl12$102
Cephalexin17$92
Hydrocortisone12$39

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Macedonia

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →